CATALAYER NEWS

How Ozempic maker Novo Nordisk blew its lead in GLP-1 weight-loss drugs. Can Europe compete in the high-stakes global economy?

Source: MarketWatch Top · 2026-08-05

Full article text is available in the Catalayer news terminal.

RELATED ON CATALAYER
Mentioned Tickers
$NVO · Novo Nordisk
RELATED MARKETS
Prediction Markets
Xi Jinping out before 2027?5%Will Gavin Newsom win the 2028 Democratic presidential nomination?14%Will Alexandria Ocasio-Cortez win the 2028 Democratic presidential nomination?21%
Open Catalayer terminal for live tracking →